Submitted by Anonymous (not verified) on 30 January 2026 - 11:00
Human medicines European public assessment report (EPAR): Scenesse, afamelanotide, Date of authorisation: 22/12/2014, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Scenesse, afamelanotide, Date of authorisation: 22/12/2014, Revision: 13, Status: Authorised